Dactinomycin 0.5’mg Injection
Indications: Dactinomycin is used in the treatment of various types of cancer, including Wilms’ tumor (a type of kidney cancer), rhabdomyosarcoma (a soft tissue cancer), Ewing’s sarcoma (a type of bone cancer), and gestational trophoblastic neoplasia (a rare cancer of the uterus)
.>IMPORTENT NOTE… Those customers who belongs to lahore avail the opportunity of cash on delivery(COD) with in 30mints.
> ALL ALTERNATIVES BRANDS ARE AVAILABLE
>ORIGNAL & IMPORTED
Indications: Dactinomycin is used in the treatment of various types of cancer, including Wilms’ tumor (a type of kidney cancer), rhabdomyosarcoma (a soft tissue cancer), Ewing’s sarcoma (a type of bone cancer), and gestational trophoblastic neoplasia (a rare cancer of the uterus).
Mechanism of Action: Dactinomycin is an anthracycline antibiotic that works by interfering with the growth and replication of cancer cells. It binds to DNA and prevents it from functioning properly, ultimately leading to the death of cancer cells.
Administration: Dactinomycin is typically administered as an intravenous (IV) injection in a healthcare facility under the supervision of a healthcare professional. The administration is carefully controlled to ensure safety and effectiveness.
Dosage: The dosage and treatment schedule for Dactinomycin depend on the specific type of cancer, the patient’s overall health, and the individualized treatment plan.
Side Effects: Common side effects of Dactinomycin can include nausea, vomiting, diarrhea, decreased blood cell counts (leading to an increased risk of infection and bleeding), and potential damage to the heart and other organs. It may also cause skin and tissue damage if accidentally injected into surrounding tissues.
Precautions: Dactinomycin may not be suitable for individuals with certain medical conditions, especially those with pre-existing heart problems, liver disease, or those taking specific medications. It’s essential to discuss any existing health conditions and medications with the healthcare provider.
Patient Education: Patients receiving Dactinomycin should be educated about the medication, its potential side effects, and the importance of adhering to the treatment plan. They should also be aware of any specific monitoring requirements.
Duration of Treatment: The duration and frequency of Dactinomycin treatment depend on the type and stage of cancer, the overall treatment plan, and the patient’s response to the medication.